Ultragenyx Pharmaceutical
RARE
RARE
172 hedge funds and large institutions have $2.79B invested in Ultragenyx Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 56 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 161 → 172 (+11)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
172
Holding in Top 10
1
Calls
$14.3M
Puts
$6.15M
Top Buyers
| 1 | +$35M | |
| 2 | +$34.1M | |
| 3 | +$27.9M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$19.2M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$18.8M |
Top Sellers
| 1 | -$43.4M | |
| 2 | -$32M | |
| 3 | -$12.8M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$12.4M |
| 5 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
-$7.6M |